Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Letvin: rAdenoviral & rMycobacterial Vector Immunogens |
| Strategy: | Vector vaccines (viral or bacterial) |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2011-04-07 |
| Study Made Public: | 2013-05-21 |
Title
rNYVAC titration in nonhuman primates
Description
CAVD 267 is a non-human primate study comparing boost regimens of increasing doses of NYVAC in subjects primed with BCG and Ad5 vaccines. This was a follow up boost study to CAVD 294.
Sign in to see full information about this study and to download study data.
Products
rNYVAC-SIV-Gag rAd5-SIV rBCG PasteurIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.